A brief history of tau: the evolving view of the microtubule-associated protein tau in neurodegenerative diseases.

The major historical milestones in tau-research are reviewed, with their implications for changing perspectives about the significance of tau-pathology in neurodegeneration. Abnormalities of tau-protein characterize the pathology of numerous neurodegenerative disorders, both sporadic and inherited. Over the years, opinions regarding the significance of tau in disease pathogenesis, particularly in Alzheimer's disease, have fluctuated. Early caution about the role of tau as a significant factor in neurodegenerative disease, especially Alzheimer's disease, has been superseded by acceptance of its key involvement in pathways which led to cell dysfunction and death. The discovery of familial "tauopathies", associated with tau-gene mutations, has confirmed that tau-dysmetabolism can independently lead to neurodegeneration. Debate about the centrality of its role remains, but current evidence makes it difficult to ignore the importance of tau in many neurodegenerative diseases. By examining the evolution of research on tau, related to advances in technology and the emergence of new diseases, the future developments needed to resolve remaining issues in the tau-story may be discerned.

[1]  A. Grover,et al.  Evidence for independent mechanisms and a multiple-hit model of tau assembly. , 2006, Biochemical and biophysical research communications.

[2]  J. Trojanowski,et al.  Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies , 2005, Acta Neuropathologica.

[3]  Michael D. Ehlers,et al.  Ubiquitin and Protein Turnover in Synapse Function , 2005, Neuron.

[4]  F. Liu,et al.  Post-translational modifications of tau protein in Alzheimer’s disease , 2005, Journal of Neural Transmission.

[5]  F. LaFerla,et al.  Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  W. Markesbery,et al.  Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. , 2005, Journal of Alzheimer's disease : JAD.

[7]  M. King Can tau filaments be both physiologically beneficial and toxic? , 2005, Biochimica et biophysica acta.

[8]  G. Hall,et al.  Modeling tauopathy: a range of complementary approaches. , 2005, Biochimica et biophysica acta.

[9]  Michel Goedert,et al.  Mutations causing neurodegenerative tauopathies. , 2005, Biochimica et biophysica acta.

[10]  Y. Han,et al.  14-3-3 Protein mediates phosphorylation of microtubule-associated protein tau by serum- and glucocorticoid-induced protein kinase 1. , 2004, Molecules and cells.

[11]  J. Cho,et al.  Glycogen Synthase Kinase 3 (cid:1) Induces Caspase-cleaved Tau Aggregation in Situ * , 2022 .

[12]  R. Brandt,et al.  Functional interactions of tau and their relevance for Alzheimer's disease. , 2004, Current Alzheimer research.

[13]  M. Pericak-Vance,et al.  Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype , 2004, Neurogenetics.

[14]  L. Barbeito,et al.  Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons. , 2004, In vivo.

[15]  Zhijian J. Chen,et al.  The novel functions of ubiquitination in signaling. , 2004, Current opinion in cell biology.

[16]  E. Kuusisto,et al.  Morphogenesis of Lewy Bodies: Dissimilar Incorporation of α‐Synuclein, Ubiquitin, and p62 , 2003, Journal of neuropathology and experimental neurology.

[17]  Leslie Wilson,et al.  Differential regulation of microtubule dynamics by three- and four-repeat tau: Implications for the onset of neurodegenerative disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Bin Zhang,et al.  Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Kazuki Sato,et al.  Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Roder Prospect of therapeutic approaches to tauopathies. , 2003 .

[21]  J. Wood,et al.  Transgenic zebrafish model of neurodegeneration , 2002, Journal of neuroscience research.

[22]  I. Grundke‐Iqbal,et al.  Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5 , 2002, Neuroscience.

[23]  S. Yen,et al.  Cellular models for tau filament assembly , 2002, Journal of Molecular Neuroscience.

[24]  M. Gold Tau therapeutics for alzheimer’s disease , 2002, Journal of Molecular Neuroscience.

[25]  M. Spillantini,et al.  Tau gene mutations: dissecting the pathogenesis of FTDP-17. , 2002, Trends in molecular medicine.

[26]  A. Lees,et al.  The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies , 2002, FEBS letters.

[27]  T. Godenschwege,et al.  New Roles for Ubiquitin in the Assembly and Function of Neuronal Circuits , 2002, Neuron.

[28]  L. Tsai,et al.  A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains , 2002, FEBS letters.

[29]  I. Ferrer,et al.  Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration , 2002, Acta Neuropathologica.

[30]  D. Dickson,et al.  Argyrophilic Grain Disease Is a Sporadic 4‐Repeat Tauopathy , 2002, Journal of neuropathology and experimental neurology.

[31]  B. Dubois,et al.  Association between the extended tau haplotype and frontotemporal dementia. , 2002, Archives of neurology.

[32]  P. Seymour,et al.  Tau protein phosphorylation as a therapeutic target in Alzheimer's disease. , 2002, Current topics in medicinal chemistry.

[33]  J. Haines,et al.  Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. , 2001, JAMA.

[34]  Khadija Iqbal,et al.  Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein. , 2001, The Journal of biological chemistry.

[35]  M N Rossor,et al.  Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype , 2001, Neurology.

[36]  Joshua M. Shulman,et al.  Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles , 2001, Science.

[37]  R. Maccioni,et al.  A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons. , 2001, Experimental cell research.

[38]  Linda Hicke,et al.  Ubiquitin and proteasomes: Protein regulation by monoubiquitin , 2001, Nature Reviews Molecular Cell Biology.

[39]  E. Matsubara,et al.  Aβ amyloidosis induces the initial stage of tau accumulation in APPSw mice , 2001, Neuroscience Letters.

[40]  T. Beach,et al.  Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy , 2001, Acta Neuropathologica.

[41]  Xiongwei Zhu,et al.  Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease , 2001, Journal of neurochemistry.

[42]  W. Markesbery,et al.  Impaired Proteasome Function in Alzheimer's Disease , 2000, Journal of neurochemistry.

[43]  R. Crowther,et al.  Abnormal tau-containing filaments in neurodegenerative diseases. , 2000, Journal of structural biology.

[44]  P. Fraser,et al.  Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. , 1999, European journal of biochemistry.

[45]  H. Braak,et al.  Distribution of Active Glycogen Synthase Kinase 3β (GSK-3β) in Brains Staged for Alzheimer Disease Neurofibrillary Changes , 1999 .

[46]  M. Hutton,et al.  Accelerated filament formation from tau protein with specific FTDP‐17 missense mutations , 1999, FEBS letters.

[47]  H. Band,et al.  Tau interacts with src-family non-receptor tyrosine kinases. , 1998, Journal of cell science.

[48]  M. Goedert,et al.  Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly , 1998, FEBS letters.

[49]  R. Tanzi,et al.  Monogenic determinants of familial Alzheimer's disease: presenilin-1 mutations , 1998, Cellular and Molecular Life Sciences CMLS.

[50]  M. Mercken,et al.  Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[51]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[52]  L. Thal,et al.  Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy , 1998, Neuroscience Letters.

[53]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[54]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[55]  H. Akiyama,et al.  Glial Tau Pathology in Neurodegenerative Diseases: Their Nature and Comparison with Neuronal Tangles , 1998, Neurobiology of Aging.

[56]  I Litvan,et al.  The clinical and pathologic hallmarks of progressive supranuclear palsy. , 1997, Current opinion in neurology.

[57]  Philip R. Cohen,et al.  Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases , 1997, FEBS letters.

[58]  U. Wagner,et al.  Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly. , 1997, The Biochemical journal.

[59]  G. Hall,et al.  Human tau becomes phosphorylated and forms filamentous deposits when overexpressed in lamprey central neurons in situ. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Khadija Iqbal,et al.  Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[61]  R. Crowther,et al.  Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans , 1996, Nature.

[62]  I. Grundke‐Iqbal,et al.  Glycosylation of microtubule–associated protein tau: An abnormal posttranslational modification in Alzheimer's disease , 1996, Nature Medicine.

[63]  U. Wagner,et al.  Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. , 1996, Journal of cell science.

[64]  M. Goedert,et al.  Protein Phosphatase 2A Is the Major Enzyme in Brain that Dephosphorylates τ Protein Phosphorylated by Proline‐Directed Protein Kinases or Cyclic AMP‐Dependent Protein Kinase , 1995 .

[65]  T. Arendt,et al.  Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease , 1995, Neuroscience.

[66]  D W Dickson,et al.  Widespread cytoskeletal pathology characterizes corticobasal degeneration. , 1995, The American journal of pathology.

[67]  R. Kalaria,et al.  Tau protein directly interacts with the amyloid β-protein precursor: Implications for Alzheimer's disease , 1995, Nature Medicine.

[68]  M. Goedert,et al.  Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. , 1995, The EMBO journal.

[69]  D. Dickson,et al.  Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. , 1994, The American journal of pathology.

[70]  Y. Ihara,et al.  Posttranslational modifications of tau in paired helical filaments. , 1994, Dementia.

[71]  I. Grundke‐Iqbal,et al.  Phosphoprotein Phosphatase Activities in Alzheimer Disease Brain , 1993, Journal of neurochemistry.

[72]  E. Mandelkow,et al.  Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding , 1993, Neuron.

[73]  J. Wood,et al.  p44mpk MAP kinase induces aizheimer type alterations in tau function and in primary hippocampal neurons , 1993 .

[74]  Yasuo Ihara,et al.  Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments , 1993, Neuron.

[75]  K. Kosik,et al.  Structure and novel exons of the human tau gene. , 1992, Biochemistry.

[76]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[77]  Bradley T. Hyman,et al.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.

[78]  R. Crowther,et al.  Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[79]  N. Cairns,et al.  Tau proteins of alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms , 1992, Neuron.

[80]  P. Mcgeer,et al.  Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue , 1992, Neuroscience Letters.

[81]  A. Delacourte,et al.  Abnormal Tau proteins in progressive supranuclear palsy , 1991, Acta Neuropathologica.

[82]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[83]  Khadija Iqbal,et al.  Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease , 1991, Brain Research.

[84]  M. Goedert,et al.  Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. , 1990, The EMBO journal.

[85]  P. Davies,et al.  A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[86]  H. Braak,et al.  CORTICAL AND SUBCORTICAL ARGYROPHILIC GRAINS CHARACTERIZE A DISEASE ASSOCIATED WITH ADULT ONSET DEMENTIA , 1989, Neuropathology and applied neurobiology.

[87]  K. Jellinger,et al.  Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease , 1989, Brain Research.

[88]  S. Love,et al.  Alz-50, Ubiquitin and Tau Immunoreactivity of Neurofibrillary Tangles, Pick Bodies and Lewy Bodies , 1988, Journal of neuropathology and experimental neurology.

[89]  K. Kosik,et al.  Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease , 1987, Annals of neurology.

[90]  D. Selkoe,et al.  Tau Epitopes are Incorporated into a Range of Lesions in Alzheimer's Disease , 1987, Journal of neuropathology and experimental neurology.

[91]  H. Wiśniewski,et al.  Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences , 1987, Acta Neuropathologica.

[92]  D. Pollen,et al.  The genetic defect causing familial Alzheimer's disease maps on chromosome 21. , 1987, Science.

[93]  N. Robakis,et al.  CHROMOSOME 21q21 SUBLOCALISATION OF GENE ENCODING BETA-AMYLOID PEPTIDE IN CEREBRAL VESSELS AND NEURITIC (SENILE) PLAQUES OF PEOPLE WITH ALZHEIMER DISEASE AND DOWN SYNDROME , 1987, The Lancet.

[94]  J. Ávila,et al.  Self assembly of microtubule associated protein tau into filaments resembling those found in Alzheimer disease. , 1986, Biochemical and biophysical research communications.

[95]  R. Neve,et al.  Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. , 1986, Brain research.

[96]  A. Delacourte,et al.  Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments , 1986, Journal of the Neurological Sciences.

[97]  S. Mirra,et al.  FILAMENTOUS AGGREGATES IN PICK'S DISEASE, PROGRESSIVE SUPRANUCLEAR PALSY, AND ALZHEIMER'S DISEASE SHARE ANTIGENIC DETERMINANTS WITH MICROTUBULE-ASSOCIATED PROTEIN, TAU , 1986, The Lancet.

[98]  J. Brion,et al.  ALZHEIMER'S DISEASE AND TAU PROTEINS , 1986, The Lancet.

[99]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[100]  S. Mirra,et al.  Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau) , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[101]  D. Selkoe,et al.  Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[102]  H. Wiśniewski,et al.  Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.

[103]  A. Frankfurter,et al.  The distribution of tau in the mammalian central nervous system , 1985, The Journal of cell biology.

[104]  G. Lindwall,et al.  The purification of tau protein and the occurrence of two phosphorylation states of tau in brain. , 1984, The Journal of biological chemistry.

[105]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[106]  G. Lindwall,et al.  Phosphorylation affects the ability of tau protein to promote microtubule assembly. , 1984, The Journal of biological chemistry.

[107]  M. Kirschner,et al.  Studies on the expression of the microtubule-associated protein, tau, during mouse brain development, with newly isolated complementary DNA probes , 1984, The Journal of cell biology.

[108]  J. Nunez,et al.  Multisite phosphorylation of τ proteins from rat brain , 1983 .

[109]  M. Kirschner,et al.  Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. , 1977, Journal of molecular biology.

[110]  M. Kirschner,et al.  Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. , 1977, Journal of molecular biology.

[111]  M. Kirschner,et al.  A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[112]  P. Mcgeer,et al.  Further observations on Tau-positive glia in the brains with progressive supranuclear palsy , 2004, Acta Neuropathologica.

[113]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[114]  R. Cuadros,et al.  Interaction of Alzheimer's disease amyloid beta peptide fragment 25-35 with tau protein, and with a tau peptide containing the microtubule binding domain. , 2004, Journal of Alzheimer's disease : JAD.

[115]  H. Braak,et al.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads , 2004, Acta Neuropathologica.

[116]  T. Tokuda,et al.  Thorn-shaped astrocytes: possibly secondarily induced tau-positive glial fibrillary tangles , 2004, Acta Neuropathologica.

[117]  M. Lerman,et al.  Isolation, characterization, and chromosomal localization of human brain cDNA clones coding for the precursor of the amyloid of brain in Alzheimer's disease, Down's syndrome and aging. , 1987, Journal of neural transmission. Supplementum.

[118]  J. Delabar,et al.  The beta amyloid protein (AD-AP) cDNA hybridizes in normal and Alzheimer individuals near the interface of 21q21 and q22.1. , 1987, Annales de genetique.

[119]  Y. Ihara,et al.  Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. , 1986, Journal of biochemistry.